Actively Recruiting

Age: 18Years +
All Genders
NCT05361694

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Led by University of Miami · Updated on 2026-04-09

1000

Participants Needed

1

Research Sites

272 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The key aim of the study is to define the two biologically and clinically distinct entities: progressive versus stable myeloma precursor conditions.

CONDITIONS

Official Title

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of MGUS or SMM according to 2014 International Myeloma Working Group criteria
  • Diagnosis confirmed by serum/urine protein electrophoresis, immunofixation, light-chain assays, bone marrow biopsy, or a combination
  • Age 18 years or older
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3
  • Competent to sign informed consent form
Not Eligible

You will not qualify if you...

  • Diagnosis of active Multiple Myeloma with detectable M-protein and evidence of end-organ damage by CRAB criteria or myeloma-defining events
  • Prior therapy for Multiple Myeloma
  • Known plasma cell or related lymphoid disorders such as lymphoplasmacytic lymphoma or Amyloid Light chain (AL) amyloidosis
  • Lack of pathological diagnosis confirmation by pathology review or Hematopathologist
  • Active symptomatic major organ disorders increasing biopsy or procedure risk (e.g., ischemic heart disease, recent myocardial infarction, active congestive heart failure, pulmonary dysfunction)
  • Active medical or psychological illnesses that increase risk or prevent informed consent
  • Pregnant or breast-feeding women
  • Prisoners

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Miami Hospitals

Miami, Florida, United States, 33136

Actively Recruiting

Loading map...

Research Team

C

Carl Landgren, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions | DecenTrialz